Silvia S. Martins, MD, PhD; Aaron Sarvet, MPH; Julian Santaella-Tenorio, MSc; et al.
free access
JAMA Psychiatry. 2017;74(5):445-455. doi:10.1001/jamapsychiatry.2017.0113
This population-based survey study examines changes in the lifetime prevalence, patterns, and associated demographics of heroin use and use disorder from 2001-2002 to 2012-2013 among the nationally representative respondents to the Epidemiologic Survey on Alcohol and Related Conditions.
Annette Erlangsen, PhD; Bo Runeson, MD, PhD; James M. Bolton, MD; et al.
free access
JAMA Psychiatry. 2017;74(5):456-464. doi:10.1001/jamapsychiatry.2017.0226
This cohort study examines the risk for developing mental disorders, suicidal behavior, and physical disorders and experiencing adverse social events among people bereaved by spousal suicide.
Ayelet Meron Ruscio, PhD; Lauren S. Hallion, PhD; Carmen C. W. Lim, MSc; et al.
free access
JAMA Psychiatry. 2017;74(5):465-475. doi:10.1001/jamapsychiatry.2017.0056
This cross-sectional study examines the worldwide prevalence of generalized anxiety disorder using DSM-5 criteria in community-based populations of varying income levels.
Janet R. Cummings, PhD; Lindsay Allen, MA; Julie Clennon, PhD; et al.
free access
JAMA Psychiatry. 2017;74(5):476-484. doi:10.1001/jamapsychiatry.2017.0303
This study examines the geographic availability of community-based specialty mental health treatment resources and how these resources are distributed by community socioeconomic status.
Florian Walter, MSc; Matthew J. Carr, PhD; Pearl L. H. Mok, PhD; et al.
free access
has audio
JAMA Psychiatry. 2017;74(5):485-492. doi:10.1001/jamapsychiatry.2017.0071
This study investigates the risks and causes of death for premature mortality among Danish patients within the first year of discharge from their first treatment at an inpatient psychiatric facility.
-
Podcast:
Premature Mortality After Recent Discharge From Inpatient Psychiatric Treatment (JAMA Psychiatry)
Paolo Fusar-Poli, MD, PhD; Grazia Rutigliano, MD; Daniel Stahl, PhD; et al.
free access
JAMA Psychiatry. 2017;74(5):493-500. doi:10.1001/jamapsychiatry.2017.0284
This UK register-based cohort study measures the proportion of individuals with a first episode of psychosis detected by At Risk Mental State services in secondary mental health services.
Meta-analysis
David Mataix-Cols, PhD; Lorena Fernández de la Cruz, PhD; Benedetta Monzani, PhD; et al.
free access
JAMA Psychiatry. 2017;74(5):501-510. doi:10.1001/jamapsychiatry.2016.3955
This systematic review and meta-analysis evaluates whether D-cycloserine is superior to placebo in augmenting the effects of cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders.
Meta-analysis
Abhishekh H. Ashok, MBBS; Yuya Mizuno, MD; Nora D. Volkow, MD; et al.
free access
JAMA Psychiatry. 2017;74(5):511-519. doi:10.1001/jamapsychiatry.2017.0135
This systematic review and meta-analysis reviews the in vivo imaging evidence for dopaminergic alterations in stimulant (cocaine, amphetamine, or methamphetamine) drug abuse or dependence.
Berk Ustun, MS; Lenard A. Adler, MD; Cynthia Rudin, PhD; et al.
free access
JAMA Psychiatry. 2017;74(5):520-526. doi:10.1001/jamapsychiatry.2017.0298
This study designs a survey for use in screening individuals to identify attention-deficit/hyperactivity disorder based on the DSM-5 criteria.
-
Invited Commentary
Good News for Screening for Adult Attention-Deficit/Hyperactivity Disorder
Philip Shaw, MB, BCh, PhD; Kwangmi Ahn, PhD; Judith L. Rapoport, MD
JAMA Psychiatry